Douglas E. Williams

Insider Reports History

Entity
Individual
Location
C/O Amgen Inc, One Amgen Center Dr, Thousand Oaks, CA
Signature
Emily Pimblett, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Douglas E. Williams:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Sana Biotechnology, Inc. EVP & President, R&D Restricted Stock Units 67.1K $369K $5.50 Mar 7, 2024 Direct
Sana Biotechnology, Inc. EVP & President, R&D Stock Option (Right to Buy) 302K Mar 7, 2024 Direct
Codiak BioSciences, Inc. President & CEO, Director Common Stock 7.66K Mar 28, 2023 Direct
Climb Bio, Inc. Director Stock Option (Right to Buy) 6.29K Nov 11, 2024 Direct
Ovid Therapeutics Inc. Director Stock Option (Right to Buy) 1.75K May 17, 2021 Direct

Insider Reports Filed by Douglas E. Williams

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CLYM Climb Bio, Inc. Nov 11, 2024 2 $0 4 Nov 12, 2024 Director
CLYM Climb Bio, Inc. Nov 8, 2024 0 $0 3 Nov 12, 2024 Director
SANA Sana Biotechnology, Inc. Mar 7, 2024 2 $0 4 Mar 8, 2024 EVP & President, R&D
SANA Sana Biotechnology, Inc. Nov 2, 2023 1 $0 4 Nov 3, 2023 EVP & President, R&D
SANA Sana Biotechnology, Inc. Apr 10, 2023 1 $0 4 Apr 11, 2023 EVP & President, R&D
SANA Sana Biotechnology, Inc. Apr 10, 2023 0 $0 3 Apr 11, 2023 EVP & President, R&D
CDAKQ Codiak BioSciences, Inc. Mar 28, 2023 1 -$7.5K 4 Mar 30, 2023 President & CEO, Director
CDAKQ Codiak BioSciences, Inc. Jan 24, 2023 1 $0 4 Jan 26, 2023 President & CEO, Director
CDAKQ Codiak BioSciences, Inc. Jan 19, 2023 3 -$2.92K 4 Jan 23, 2023 President and Chief Executive Officer, Director
CDAKQ Codiak BioSciences, Inc. Aug 16, 2022 6 -$20.3K 4 Feb 21, 2023 President & CEO, Director
CDAKQ Codiak BioSciences, Inc. Feb 16, 2022 2 $0 4 Feb 18, 2022 President & CEO, Director
CDAKQ Codiak BioSciences, Inc. Jan 19, 2022 2 $0 4 Jan 21, 2022 President & CEO
OVID Ovid Therapeutics Inc. May 17, 2021 1 $0 4 May 18, 2021 Director